Lawmakers contemplate the return of mental health institutions in response to the drug crisis; new measures to rein in insulin prices take effect; FDA intensifies efforts to curb the teen vaping epidemic.
Congress is deliberating the revival of mental hospitals as a response to the escalating drug crisis, according to Politico. The proposal, while aiming to provide comprehensive care for individuals struggling with substance use disorders and mental health issues, has generated significant controversy. Supporters argue for a holistic approach, while critics express concerns about potential stigmatization and the need for more nuanced solutions in addressing the complex intersection of mental health and drug addiction.
In response to growing concerns over rising insulin prices, major insulin manufacturers, including Sanofi, Novo Nordisk, and Eli Lilly, have initiated measures added price caps and have made substantial reductions in list prices, which took effect on January 1, according to CNN. Sanofi has instituted a $35 monthly cap on out-of-pocket costs for its most widely prescribed insulin in the United States, following Novo Nordisk and Eli Lilly, which placed insulin caps on their products in 2023. The moves should make insulin more affordable for the 8.4 million Americans dependent on the life-saving medication, coming in response to mounting public pressure, changes in Medicaid rebate programs, and the entry of new competitors.
The FDA's recent crackdown on the importation of Elf Bar, a widely popular e-cigarette brand, is indicative of an escalated campaign against teen vaping, although thousands of other flavored e-cigarettes continue to make their way into the nation, according to The Associated Press. As health authorities grapple with the rising rates of youth nicotine addiction, the efforts to seize shipments of e-cigarettes are both applauded for their potential impact on public health and criticized for potential unintended consequences. The move underscores the ongoing challenge of balancing access for adult smokers seeking harm reduction with the imperative to protect younger generations from the dangers of nicotine addiction.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More